: a cinderella fusion in lung cancer?
作者信息
Muscarella Lucia Anna, Rossi Antonio
机构信息
Laboratory of Oncology, Scientific Institute for Research & Health Care (IRCCS) 'Casa Sollievo della Sofferenza', San Giovanni Rotondo (FG), Italy.
Division of Medical Oncology, Scientific Institute for Research & Health Care (IRCCS), Casa Sollievo della Sofferenza Hospital, Viale Cappuccini 1, 71013, San Giovanni Rotondo (FG), Italy.
出版信息
Lung Cancer Manag. 2017 Dec;6(4):121-123. doi: 10.2217/lmt-2017-0018. Epub 2018 Jan 5.
Abstract
摘要
相似文献
1
: a cinderella fusion in lung cancer?肺癌中的一种灰姑娘融合现象？
Lung Cancer Manag. 2017 Dec;6(4):121-123. doi: 10.2217/lmt-2017-0018. Epub 2018 Jan 5.
2
NRG1-ErbB Lost in Translation: A New Paradigm for Lung Cancer?NRG1-ErbB翻译缺失：肺癌的一种新范式？
Curr Med Chem. 2017;24(38):4213-4228. doi: 10.2174/0929867324666170911170554.
3
Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lung.SLC3A2-NRG1融合在肺浸润性黏液腺癌中的致癌功能及临床意义
Oncotarget. 2016 Oct 25;7(43):69450-69465. doi: 10.18632/oncotarget.11913.
4
VAMP2-NRG1 Fusion Gene is a Novel Oncogenic Driver of Non-Small-Cell Lung Adenocarcinoma.VAMP2-NRG1 融合基因是一种新型非小细胞肺腺癌致癌驱动基因。
J Thorac Oncol. 2015 Jul;10(7):1107-11. doi: 10.1097/JTO.0000000000000544.
5
Oncogenic Fusion Gene CD74-NRG1 Confers Cancer Stem Cell-like Properties in Lung Cancer through a IGF2 Autocrine/Paracrine Circuit.致癌融合基因 CD74-NRG1 通过 IGF2 自分泌/旁分泌环赋予肺癌肿瘤干细胞样特性。
Cancer Res. 2016 Feb 15;76(4):974-83. doi: 10.1158/0008-5472.CAN-15-2135. Epub 2016 Feb 2.
6
Neuregulin-1-ErbB signaling promotes microglia activation contributing to mechanical allodynia of cyclophosphamide-induced cystitis.神经调节蛋白 1-ErbB 信号促进小胶质细胞激活，导致环磷酰胺诱导的膀胱炎的机械性痛觉过敏。
Neurourol Urodyn. 2019 Jun;38(5):1250-1260. doi: 10.1002/nau.24005. Epub 2019 Apr 15.
7
[Endogenous neuregulin-1 expression in the anterior pituitary of female Wistar-Furth rats during the estrous cycle].[雌性Wistar-Furth大鼠发情周期中垂体前叶内源性神经调节蛋白-1的表达]
Nan Fang Yi Ke Da Xue Xue Bao. 2011 Jun;31(6):921-7.
8
Astraglaus polysaccharide protects diabetic cardiomyopathy by activating NRG1/ErbB pathway.黄芪多糖通过激活 NRG1/ErbB 通路保护糖尿病心肌病。
Biosci Trends. 2018 May 13;12(2):149-156. doi: 10.5582/bst.2018.01027. Epub 2018 Apr 2.
9
NRG1-ErbB signalling promotes microglia activation contributing to incision-induced mechanical allodynia.NRG1-ErbB信号通路促进小胶质细胞活化，导致切口诱导的机械性异常性疼痛。
Eur J Pain. 2015 May;19(5):686-94. doi: 10.1002/ejp.590. Epub 2014 Aug 27.
10
Effects of prolonged antipsychotic administration on neuregulin-1/ErbB signaling in rat prefrontal cortex and myocardium: implications for the therapeutic action and cardiac adverse effect.长期使用抗精神病药物对大鼠前额叶皮质和心肌中神经调节蛋白-1/表皮生长因子受体（ErbB）信号通路的影响：对治疗作用和心脏不良反应的启示
J Toxicol Sci. 2016 Apr;41(2):303-9. doi: 10.2131/jts.41.303.
引用本文的文献
1
Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer.神经调节蛋白-1 和 ALS19（表皮生长因子受体 4）：肌萎缩侧索硬化症和癌症的交汇点。
BMC Med. 2024 Feb 19;22(1):74. doi: 10.1186/s12916-024-03293-3.
2
Oncogenic alterations in advanced NSCLC: a molecular super-highway.晚期非小细胞肺癌中的致癌改变：一条分子高速公路。
Biomark Res. 2024 Feb 12;12(1):24. doi: 10.1186/s40364-024-00566-0.
3
Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics.肿瘤学中的无偏见批准：通过正确的基因组学将正确的药物给予正确的患者。
Pharmaceuticals (Basel). 2023 Apr 19;16(4):614. doi: 10.3390/ph16040614.
4
Neuregulin 1 Gene (). A Potentially New Targetable Alteration for the Treatment of Lung Cancer.神经调节蛋白1基因（）。肺癌治疗中一个潜在的新的可靶向改变。
Cancers (Basel). 2021 Oct 9;13(20):5038. doi: 10.3390/cancers13205038.
5
The impact of fusion genes on cancer stem cells and drug resistance.融合基因对癌症干细胞和耐药性的影响。
Mol Cell Biochem. 2021 Oct;476(10):3771-3783. doi: 10.1007/s11010-021-04203-4. Epub 2021 Jun 7.
6
Clinicopathologic Features and Response to Therapy of Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry.融合驱动型肺癌的临床病理特征和治疗反应：eNRGy1 全球多中心注册研究。
J Clin Oncol. 2021 Sep 1;39(25):2791-2802. doi: 10.1200/JCO.20.03307. Epub 2021 Jun 2.
7
Oncogenic driver mutations in non-small cell lung cancer: Past, present and future.非小细胞肺癌中的致癌驱动基因突变：过去、现在与未来
World J Clin Oncol. 2021 Apr 24;12(4):217-237. doi: 10.5306/wjco.v12.i4.217.
8
An improved assay for detection of theranostic gene translocations and MET exon 14 skipping in thoracic oncology.一种改良的检测方法，用于检测胸肿瘤治疗相关基因易位和 MET 外显子 14 跳跃
Lab Invest. 2021 May;101(5):648-660. doi: 10.1038/s41374-021-00536-2. Epub 2021 Jan 25.
9
Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes.他洛昔替尼是一种缺氧激活的泛HER激酶抑制剂，对多种HER家族癌基因具有活性。
Clin Cancer Res. 2021 Mar 1;27(5):1463-1475. doi: 10.1158/1078-0432.CCR-20-3555. Epub 2020 Dec 22.
10
Recent Progress in Rare Oncogenic Drivers and Targeted Therapy For Non-Small Cell Lung Cancer.非小细胞肺癌罕见致癌驱动因素与靶向治疗的最新进展
Onco Targets Ther. 2019 Nov 28;12:10343-10360. doi: 10.2147/OTT.S230309. eCollection 2019.
本文引用的文献
1
NRG1-dependent activation of HER3 induces primary resistance to trastuzumab in HER2-overexpressing breast cancer cells.NRG1 依赖性激活 HER3 诱导 HER2 过表达乳腺癌细胞对曲妥珠单抗的原发耐药。
Int J Oncol. 2017 Nov;51(5):1553-1562. doi: 10.3892/ijo.2017.4130. Epub 2017 Sep 21.
2
A Molecularly Annotated Model of Patient-Derived Colon Cancer Stem-Like Cells to Assess Genetic and Nongenetic Mechanisms of Resistance to Anti-EGFR Therapy.一种分子注释的患者来源结肠癌干细胞样细胞模型，用于评估抗 EGFR 治疗耐药的遗传和非遗传机制。
Clin Cancer Res. 2018 Feb 15;24(4):807-820. doi: 10.1158/1078-0432.CCR-17-2151. Epub 2017 Oct 3.
3
Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer.成功靶向 NRG1 通路为转移性癌症提供了新的治疗策略。
Ann Oncol. 2017 Dec 1;28(12):3092-3097. doi: 10.1093/annonc/mdx523.
4
ALK and NRG1 Fusions Coexist in a Patient with Signet Ring Cell Lung Adenocarcinoma.一名印戒细胞肺腺癌患者中ALK和NRG1融合共存。
J Thorac Oncol. 2017 Oct;12(10):e161-e163. doi: 10.1016/j.jtho.2017.05.014.
5
NRG1-ErbB Lost in Translation: A New Paradigm for Lung Cancer?NRG1-ErbB翻译缺失：肺癌的一种新范式？
Curr Med Chem. 2017;24(38):4213-4228. doi: 10.2174/0929867324666170911170554.
6
Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance.实体瘤中的融合基因：诊断策略、靶向治疗及获得性耐药
Nat Rev Clin Oncol. 2017 Dec;14(12):735-748. doi: 10.1038/nrclinonc.2017.127. Epub 2017 Aug 31.
7
Durable Response to Afatinib in Lung Adenocarcinoma Harboring NRG1 Gene Fusions.携带NRG1基因融合的肺腺癌对阿法替尼的持久反应
J Thorac Oncol. 2017 Aug;12(8):e107-e110. doi: 10.1016/j.jtho.2017.04.025. Epub 2017 May 10.
8
KIF13B-NRG1 Gene Fusion and KRAS Amplification in a Case of Natural Progression of Lung Cancer.一例肺癌自然进展病例中的KIF13B-NRG1基因融合与KRAS扩增
Int J Surg Pathol. 2017 May;25(3):238-240. doi: 10.1177/1066896917693092.
9
Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lung.SLC3A2-NRG1融合在肺浸润性黏液腺癌中的致癌功能及临床意义
Oncotarget. 2016 Oct 25;7(43):69450-69465. doi: 10.18632/oncotarget.11913.
10
Targeting HER3 using mono- and bispecific antibodies or alternative scaffolds.使用单特异性和双特异性抗体或其他支架靶向HER3。
MAbs. 2016 Oct;8(7):1195-1209. doi: 10.1080/19420862.2016.1212147. Epub 2016 Aug 17.
Zotero 插件